Results 81 to 90 of about 673 (120)

Surgical treatment for Xp11.2 translocation renal cell carcinoma with venous thrombus: A STROBE-compliant study. [PDF]

Medicine (Baltimore), 2019
Ge L, Tian X, Ma J, Zhao G, Song Y, Zhang S, Ma L.   +6 more
europepmc   +1 more source

Clinicopathological Features and Prognostic Factors of Renal Cell Carcinoma in Young Patients Under 45 Years: A Single-Center Retrospective Study

Cancer Management and Research
Yu Gao,1,* Haisheng Yan,2,* Tao Zhang,2 Guanjun Lu,1 Lianghong Ma1,3 1Urology Department of General Hospital of Ningxia Medical University, Yinchuan, 750004, People’s Republic of China; 2The First Clinical Medical College, Ningxia Medical
Gao Y, Yan H, Zhang T, Lu G, Ma L
doaj  

MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma. [PDF]

Cancer Sci, 2019
Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K, Eto M, Schmidt LS, Kamba T, Linehan WM, Oike Y.   +14 more
europepmc   +1 more source

Incidence and significance of psammoma bodies in Xp11.2 translocation renal cell carcinoma and papillary renal cell carcinoma. [PDF]

Oncol Lett, 2019
Liu N, Qu F, Wei K, Gan W, Wang Z, Zhuang W, Agizamhan S, Ma W, Yang J, Chen M, Xu L, Guo H, Li D.   +12 more
europepmc   +1 more source

Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report. [PDF]

Mol Clin Oncol, 2018
Pan X, Quan J, Zhao L, Li W, Wei B, Yang S, Lai Y.   +6 more
europepmc   +1 more source

TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease. [PDF]

Mol Cancer Res, 2019
Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM.   +31 more
europepmc   +1 more source

Imaging hallmark of Xp11.2 translocation renal cell carcinoma. [PDF]

Can Urol Assoc J, 2015
Sureka B, Bansal K, Arora A.
europepmc   +1 more source

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function. [PDF]

Korean J Intern Med, 2017
Huh H, Jo HA, Yi Y, Kim SH, Moon KC, Ahn C, Park HC.   +6 more
europepmc   +1 more source

Clinicopathological features of Xp11.2 translocation renal cell carcinoma. [PDF]

Korean J Urol, 2015
Lim B, You D, Jeong IG, Kwon T, Hong S, Song C, Cho YM, Hong B, Hong JH, Ahn H, Kim CS.   +10 more
europepmc   +1 more source

Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report. [PDF]

Oncol Lett, 2016
Liu J, Su Z, Li Y, Chen D, Ni L, Mao X, Yang S, Lai Y.   +7 more
europepmc   +1 more source